Novartis India Ltd share price logo

Novartis India Ltd

NSE: NOVARTIND

BSE: 500672

Small Cap

Pharma Sector

₹1295.90

+86.10

(+7.12%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Novartis India Stock Performance

as on May 20, 2026 at 6:59 pm IST

  • Day's Low

    Day's High

    ₹1,209.00
    ₹1,310.00
    downward going graph

    6.71%

    Downside

    1.09%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹950.00
    ₹1,310.00
    downward going graph

    26.69%

    Downside

    1.09%

    Upside

    downward going graph

Novartis India share price movements today

Previous Close
₹1,209.80
Open
₹1,292.80
Volume
48.01K
Upper Circuit
₹1,451.70
Lower Circuit
₹967.90
Day's Low - High
₹1,209.00 - ₹1,310.00
52 Week Low - High
₹950.00 - ₹1,310.00

Novartis India Historical Returns

1 Month Return
+ 21.53 %
3 Month Return
+ 21.4 %
1 Year Return
+ 34.51 %
3 Year Return
+ 72.09 %
5 Year Return
+ 93.12 %

Novartis India Fundamentals

as on May 20, 2026 at 1:29 pm IST

Market Cap

₹2,987.09 Cr

Return on Equity (ROE)

13.19

PE Ratio (TTM)

0

Return on capital employed (ROCE)

16.64

Beta (LTM)

-1.72

P/B Ratio

2.47

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-13.82

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Novartis India Technical Analysis

Track how Novartis India technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish6
Bullish7
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
1.23
Bearish
CCI (20)
-498.11
Bullish
RSI (14)
48.38
Neutral
Momentum (10)
-4.9
Bearish
ADI (14)
17.03
Neutral
Ultimate Oscillator (7,14,28)
76.37
Bullish

Moving Averages

Name

Value

Action

SMA (20)
1297.33
Bearish
EMA (20)
1296.7
Bearish
VWMA (20)
1297.74
Bearish
SMA (50)
1291.95
Bullish
EMA (50)
1294.61
Bullish
SMA (200)
1281.66
Bullish
EMA (200)
1279.57
Bullish
KAMA (200)
1292.18
Bullish
DEMA (200)
1304.14
Bearish

Novartis India Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Novartis India with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Novartis India Ltd image
Novartis India Ltd
NA2,987.0918.62%0.00100390
Aarti Pharmalabs Ltd image
Aarti Pharmalabs Ltd
BUY6,399.5328.98%0.592722,115
Wanbury Ltd image
Wanbury Ltd
NA901.7930.21%0.8830599
Shukra Pharmaceuticals Ltd image
Shukra Pharmaceuticals Ltd
NA1,328.531460%0.00932
Pfizer Ltd image
Pfizer Ltd
BUY21,892.12-1.75%0.00NANA
See all

Novartis India Stock’s Investor Sentiment and Interest

Search interest for Novartis India Ltd Stock has increased by 107% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:107% versus previous 30 day period

Novartis India Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
90.6
78.76
84.54
81.17
92.29
87.1
93
83.88
87.55
90.33
85.9
90.55
Other Income
12.42
16.88
21.96
10.42
10.41
10.32
10.6
10.63
10.61
9.4
8.75
10.01
Total Income
103.02
95.64
106.5
91.59
102.7
97.42
103.6
94.51
98.16
99.73
94.65
100.56
Expenses
73.23
61.85
64.77
69.96
68.32
69.14
67.42
59.97
60.31
66.45
63.54
69.93
Operating Profit
17.37
16.91
19.77
11.21
23.97
17.96
25.58
23.91
27.24
23.88
22.36
20.62
Operating Profit Margin %
19.17%
21.47%
23.39%
13.81%
25.97%
20.62%
27.51%
28.51%
31.11%
26.44%
26.03%
22.77%
Profit Before Interest, Tax and Depreciation
29.79
33.79
41.73
21.63
34.38
28.28
36.18
34.54
37.85
33.28
31.11
30.63
Interest
0.46
0.71
0.16
0.16
0.15
0.14
0.36
0.12
0.1
0.11
0.98
0.07
Depreciation
1.56
0.65
0.26
0.14
0.55
0.58
0.53
0.53
0.53
0.52
0.48
0.42
Profit Before Tax
27.77
32.43
41.31
21.33
33.68
27.56
35.29
33.89
37.22
32.65
29.65
30.14
Tax Paid
7.51
8.75
14.74
6.65
7.94
7.15
9.84
4.59
9.6
8.43
13.56
4.89
Profit After Tax
20.26
23.68
26.57
14.68
25.74
20.41
25.45
29.3
27.62
24.22
16.09
25.25
Total Net profit including share of profit / Loss from associate company
20.26
23.68
26.57
14.68
25.74
20.41
25.45
29.3
27.62
24.22
16.09
25.25
EPS
8.21
9.59
10.76
5.95
10.42
8.27
10.31
11.87
11.19
9.81
6.52
10.23
Actual EPS
8.21
9.59
10.76
5.95
10.42
8.27
10.31
11.87
11.19
9.81
6.52
10.23
Adjusted EPS
8.21
9.59
10.76
5.95
10.42
8.27
10.31
11.87
11.19
9.81
6.52
10.23
Diluted EPS
8.21
9.59
10.76
5.95
10.42
8.27
10.31
11.87
11.19
9.81
6.52
10.23

Novartis India Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
563.88
490.68
438.25
381.35
399.87
378.74
335.07
356.27
354.33
Other Income
171.83
78.26
36.14
33.09
33.19
58.11
61.68
41.96
38.77
Total Income
735.71
568.94
474.39
414.44
433.06
436.85
396.75
398.23
393.1
Expenses
570.13
478.4
426.22
354.56
422.4
313.66
269.81
264.85
260.23
Operating Profit
-6.25
12.28
12.03
26.79
-22.53
65.08
65.26
91.42
94.1
Operating Profit Margin %
-1.11%
2.5%
2.75%
7.03%
-5.63%
17.18%
19.48%
25.66%
26.56%
Profit Before Interest, Tax and Depreciation
165.58
90.54
48.17
59.88
10.66
123.19
126.94
133.38
132.87
Interest
5.53
1.59
6.39
7.68
4.83
1.75
1.49
0.77
1.26
Depreciation
2.53
3.18
13.14
12.16
9.65
6.06
2.61
2.19
1.95
Profit Before Tax
157.52
85.77
28.64
40.04
-3.82
115.38
122.84
130.42
129.66
Tax Paid
79.16
34
18.56
19.14
-0.1
12.02
37.65
29.52
36.48
Profit After Tax
78.36
51.77
10.08
20.9
-3.72
103.36
85.19
100.9
93.18
Total Net profit including share of profit / Loss from associate company
78.36
51.77
10.08
20.9
-3.72
103.36
85.19
100.9
93.18
EPS
28.43
20.97
4.08
8.46
-1.51
41.86
34.5
40.87
37.74
Actual EPS
28.43
20.97
4.08
8.46
-1.51
41.86
34.5
40.87
37.74
Adjusted EPS
28.43
20.97
4.08
8.46
-1.51
41.86
34.5
40.87
37.74
Diluted EPS
28.43
20.97
4.08
8.46
-1.51
41.86
34.5
40.87
37.74

Novartis India Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
56.59
-40.83
160.99
-194.28
-23.14
-69.21
38.67
44.8
113.4
74.57
Cash Flow from Investing Activities
-630.47
423.64
68.7
274.23
55.91
95.16
87.04
-153.25
33.13
-3.31
Cash Flow from Financing Activities
-38.57
-331.8
-267.65
-29.82
-41.41
-36.8
-35.63
-30.48
-120.99
-64.15
Net Cash Flow
-612.45
51.01
-37.96
50.13
-8.64
-10.85
90.08
-138.93
25.54
7.11

Novartis India Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
DII
0.76%
0.53%
0.53%
0.53%
0.53%
0.53%
0.53%
0.53%
0.53%
0.53%
0.64%
0.53%
FII
0%
0.32%
0.19%
0.19%
0.19%
0.19%
0.19%
0.19%
0.19%
0.19%
0.19%
0.17%
Public
28.32%
28.47%
28.59%
28.6%
28.6%
28.6%
28.6%
28.6%
28.6%
28.6%
28.5%
28.61%
Total Outstanding Shares
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
Total Shareholders
43,343
43,992
43,128
41,239
39,265
39,596
38,926
39,133
39,040
39,353
39,468
38,116

Mutual Funds that own Novartis India Stock

Check out the Mutual Funds with significant holdings in Novartis India.

Novartis India Corporate Actions

View detailed summary of the earnings and dividend history of Novartis India.

  • Novartis India Ltd Earnings Results

    Novartis India Ltd’s net profit fell -13.82% since last year same period to ₹25.25Cr in the Q4 2025-2026. On a quarterly growth basis, Novartis India Ltd has generated 56.93% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Novartis India Ltd Dividends May,2025

    In the quarter ending March 2025, Novartis India Ltd has declared dividend of ₹25.00 per share on 09 May 2025 - translating a dividend yield of 4.23%.

    Read More about Dividends

Indices Featuring Novartis India Stock

Check stock indices that include Novartis India.

BSE Healthcare

₹47,565.41

0.01 (▲5.31%)

Insights on Novartis India Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 28.50% to 28.62% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, NOVARTIND stock has moved up by 21.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 167.1% return, outperforming this stock by 95.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.68% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 37.6% return, outperforming this stock by 3.1%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.19% to 0.17% in Mar 2026 quarter

About Novartis India Ltd

Novartis India Limited (NIL) is a subsidiary of the world's second-largest pharmaceutical company, Swiss giant Novartis. Incorporated in 1947, the company has four core segments- Pharmaceuticals, Generics, Over the Counter, and Animal Health. Its history traces back to the middle of the 18th century when Geigy was founded, followed by Ciba in 1860 and then Sandoz in 1886. It was only in 1996 when the three separate entities merged to become Novartis. In 2000, the company acquired products from SmithKline Beecham and started a Joint Effort to Eradicate Tuberculosis (JEET) in India. The Glivec drug was launched in India in 2002 for which they were awarded TERI's Corporate Social Responsibility award. Over the years the company has alligned with various global organisations inlcuding the WHO to help stem the spread of malaria, as well as launching numerous initiatives including the Arogya Parivar in 2008 to target healthcare needs of villagers. Moreover, between 2000 and 2006, it spent over USD 755 million on research for neglected diseases and patient-access programs.

Revenue: ₹90.55Cr as on March 2026 (Q4 FY26)
Net Profit: ₹25.25Cr as on March 2026 (Q4 FY26)
Listing date: 08 Nov, 1994
Chairperson Name: C Snook
OrganisationNovartis India Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOC Snook
E-voting on sharesClick here to vote

FAQs

What is Novartis India share price today?

Novartis India share price today stands at ₹1295.9 as on . Novartis India share today touched a day high of ₹1310 and a low of ₹1209.

What is the 52 week high and 52 week low range for Novartis India share?

Novartis India touched a 52 week high of ₹1310 and a 52 week low of ₹950. Novartis India share price today i.e. is trending at ₹1295.9, which is -1.08% down from its 52 week high and 36.41% up from its 52 week low.

What is Novartis India's market capitalisation today?

Novartis India market capitalisation is ₹2,987.09 Cr as on .

How to buy Novartis India shares?

To buy Novartis India shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for NOVARTIND or Novartis India Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Novartis India shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Novartis India trading volume today?

Novartis India trading volume is 48.01K as on . This means that 48.01K shares of Novartis India were bought and sold on the stock market during today's trading session.